img

Global Erectile Dysfunction Oral Medications Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Erectile Dysfunction Oral Medications Market Insights, Forecast to 2034

Sildenafil (Viagra), vardenafil (Levitra, Staxyn), tadalafil (Cialis) and avanafil (Stendra) are oral medications that reverse erectile dysfunction by enhancing the effects of nitric oxide, a natural chemical your body produces that relaxes muscles in the penis.
Global Erectile Dysfunction Oral Medications market is expected to reach to US$ 135 million in 2024, with a positive growth of %, compared with US$ 131 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Erectile Dysfunction Oral Medications industry is evaluated to reach US$ 166.9 million in 2029. The CAGR will be 3.6% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Erectile Dysfunction Oral Medications market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Erectile Dysfunction Oral Medications market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Eli Lilly
Pfizer
Bayer
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
BaiYunShan General Factory
Yabang Pharmacy
Segment by Type
Sildenafil
Tadalafil
Others

Segment by Application


Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Erectile Dysfunction Oral Medications plant distribution, commercial date of Erectile Dysfunction Oral Medications, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Erectile Dysfunction Oral Medications introduction, etc. Erectile Dysfunction Oral Medications Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Erectile Dysfunction Oral Medications
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Erectile Dysfunction Oral Medications Product Introduction
1.2 Market by Type
1.2.1 Global Erectile Dysfunction Oral Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Market by Application
1.3.1 Global Erectile Dysfunction Oral Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Erectile Dysfunction Oral Medications Sales Estimates and Forecasts 2018-2029
2.2 Global Erectile Dysfunction Oral Medications Revenue by Region
2.2.1 Global Erectile Dysfunction Oral Medications Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Erectile Dysfunction Oral Medications Revenue by Region (2018-2024)
2.2.3 Global Erectile Dysfunction Oral Medications Revenue by Region (2024-2029)
2.2.4 Global Erectile Dysfunction Oral Medications Revenue Market Share by Region (2018-2029)
2.3 Global Erectile Dysfunction Oral Medications Sales Estimates and Forecasts 2018-2029
2.4 Global Erectile Dysfunction Oral Medications Sales by Region
2.4.1 Global Erectile Dysfunction Oral Medications Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Erectile Dysfunction Oral Medications Sales by Region (2018-2024)
2.4.3 Global Erectile Dysfunction Oral Medications Sales by Region (2024-2029)
2.4.4 Global Erectile Dysfunction Oral Medications Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Erectile Dysfunction Oral Medications Sales by Manufacturers
3.1.1 Global Erectile Dysfunction Oral Medications Sales by Manufacturers (2018-2024)
3.1.2 Global Erectile Dysfunction Oral Medications Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Erectile Dysfunction Oral Medications in 2022
3.2 Global Erectile Dysfunction Oral Medications Revenue by Manufacturers
3.2.1 Global Erectile Dysfunction Oral Medications Revenue by Manufacturers (2018-2024)
3.2.2 Global Erectile Dysfunction Oral Medications Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Erectile Dysfunction Oral Medications Revenue in 2022
3.3 Global Key Players of Erectile Dysfunction Oral Medications, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Erectile Dysfunction Oral Medications Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Erectile Dysfunction Oral Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Erectile Dysfunction Oral Medications, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Erectile Dysfunction Oral Medications, Product Offered and Application
3.8 Global Key Manufacturers of Erectile Dysfunction Oral Medications, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Erectile Dysfunction Oral Medications Sales by Type
4.1.1 Global Erectile Dysfunction Oral Medications Historical Sales by Type (2018-2024)
4.1.2 Global Erectile Dysfunction Oral Medications Forecasted Sales by Type (2024-2029)
4.1.3 Global Erectile Dysfunction Oral Medications Sales Market Share by Type (2018-2029)
4.2 Global Erectile Dysfunction Oral Medications Revenue by Type
4.2.1 Global Erectile Dysfunction Oral Medications Historical Revenue by Type (2018-2024)
4.2.2 Global Erectile Dysfunction Oral Medications Forecasted Revenue by Type (2024-2029)
4.2.3 Global Erectile Dysfunction Oral Medications Revenue Market Share by Type (2018-2029)
4.3 Global Erectile Dysfunction Oral Medications Price by Type
4.3.1 Global Erectile Dysfunction Oral Medications Price by Type (2018-2024)
4.3.2 Global Erectile Dysfunction Oral Medications Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Erectile Dysfunction Oral Medications Sales by Application
5.1.1 Global Erectile Dysfunction Oral Medications Historical Sales by Application (2018-2024)
5.1.2 Global Erectile Dysfunction Oral Medications Forecasted Sales by Application (2024-2029)
5.1.3 Global Erectile Dysfunction Oral Medications Sales Market Share by Application (2018-2029)
5.2 Global Erectile Dysfunction Oral Medications Revenue by Application
5.2.1 Global Erectile Dysfunction Oral Medications Historical Revenue by Application (2018-2024)
5.2.2 Global Erectile Dysfunction Oral Medications Forecasted Revenue by Application (2024-2029)
5.2.3 Global Erectile Dysfunction Oral Medications Revenue Market Share by Application (2018-2029)
5.3 Global Erectile Dysfunction Oral Medications Price by Application
5.3.1 Global Erectile Dysfunction Oral Medications Price by Application (2018-2024)
5.3.2 Global Erectile Dysfunction Oral Medications Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Erectile Dysfunction Oral Medications Market Size by Type
6.1.1 US & Canada Erectile Dysfunction Oral Medications Sales by Type (2018-2029)
6.1.2 US & Canada Erectile Dysfunction Oral Medications Revenue by Type (2018-2029)
6.2 US & Canada Erectile Dysfunction Oral Medications Market Size by Application
6.2.1 US & Canada Erectile Dysfunction Oral Medications Sales by Application (2018-2029)
6.2.2 US & Canada Erectile Dysfunction Oral Medications Revenue by Application (2018-2029)
6.3 US & Canada Erectile Dysfunction Oral Medications Market Size by Country
6.3.1 US & Canada Erectile Dysfunction Oral Medications Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Erectile Dysfunction Oral Medications Sales by Country (2018-2029)
6.3.3 US & Canada Erectile Dysfunction Oral Medications Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Erectile Dysfunction Oral Medications Market Size by Type
7.1.1 Europe Erectile Dysfunction Oral Medications Sales by Type (2018-2029)
7.1.2 Europe Erectile Dysfunction Oral Medications Revenue by Type (2018-2029)
7.2 Europe Erectile Dysfunction Oral Medications Market Size by Application
7.2.1 Europe Erectile Dysfunction Oral Medications Sales by Application (2018-2029)
7.2.2 Europe Erectile Dysfunction Oral Medications Revenue by Application (2018-2029)
7.3 Europe Erectile Dysfunction Oral Medications Market Size by Country
7.3.1 Europe Erectile Dysfunction Oral Medications Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Erectile Dysfunction Oral Medications Sales by Country (2018-2029)
7.3.3 Europe Erectile Dysfunction Oral Medications Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Erectile Dysfunction Oral Medications Market Size
8.1.1 China Erectile Dysfunction Oral Medications Sales (2018-2029)
8.1.2 China Erectile Dysfunction Oral Medications Revenue (2018-2029)
8.2 China Erectile Dysfunction Oral Medications Market Size by Application
8.2.1 China Erectile Dysfunction Oral Medications Sales by Application (2018-2029)
8.2.2 China Erectile Dysfunction Oral Medications Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Erectile Dysfunction Oral Medications Market Size by Type
9.1.1 Asia Erectile Dysfunction Oral Medications Sales by Type (2018-2029)
9.1.2 Asia Erectile Dysfunction Oral Medications Revenue by Type (2018-2029)
9.2 Asia Erectile Dysfunction Oral Medications Market Size by Application
9.2.1 Asia Erectile Dysfunction Oral Medications Sales by Application (2018-2029)
9.2.2 Asia Erectile Dysfunction Oral Medications Revenue by Application (2018-2029)
9.3 Asia Erectile Dysfunction Oral Medications Sales by Region
9.3.1 Asia Erectile Dysfunction Oral Medications Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Erectile Dysfunction Oral Medications Revenue by Region (2018-2029)
9.3.3 Asia Erectile Dysfunction Oral Medications Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Market Size by Type
10.1.1 Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Market Size by Application
10.2.1 Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Sales by Country
10.3.1 Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Information
11.1.2 Eli Lilly Overview
11.1.3 Eli Lilly Erectile Dysfunction Oral Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Eli Lilly Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Eli Lilly Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Erectile Dysfunction Oral Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Pfizer Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Overview
11.3.3 Bayer Erectile Dysfunction Oral Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Bayer Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer Recent Developments
11.4 S.K. Chemicals
11.4.1 S.K. Chemicals Company Information
11.4.2 S.K. Chemicals Overview
11.4.3 S.K. Chemicals Erectile Dysfunction Oral Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 S.K. Chemicals Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 S.K. Chemicals Recent Developments
11.5 Teva Pharma
11.5.1 Teva Pharma Company Information
11.5.2 Teva Pharma Overview
11.5.3 Teva Pharma Erectile Dysfunction Oral Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Teva Pharma Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Teva Pharma Recent Developments
11.6 Dong-A ST
11.6.1 Dong-A ST Company Information
11.6.2 Dong-A ST Overview
11.6.3 Dong-A ST Erectile Dysfunction Oral Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Dong-A ST Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Dong-A ST Recent Developments
11.7 Petros Pharmaceuticals
11.7.1 Petros Pharmaceuticals Company Information
11.7.2 Petros Pharmaceuticals Overview
11.7.3 Petros Pharmaceuticals Erectile Dysfunction Oral Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Petros Pharmaceuticals Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Petros Pharmaceuticals Recent Developments
11.8 Seoul Pharma
11.8.1 Seoul Pharma Company Information
11.8.2 Seoul Pharma Overview
11.8.3 Seoul Pharma Erectile Dysfunction Oral Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Seoul Pharma Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Seoul Pharma Recent Developments
11.9 BaiYunShan General Factory
11.9.1 BaiYunShan General Factory Company Information
11.9.2 BaiYunShan General Factory Overview
11.9.3 BaiYunShan General Factory Erectile Dysfunction Oral Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 BaiYunShan General Factory Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 BaiYunShan General Factory Recent Developments
11.10 Yabang Pharmacy
11.10.1 Yabang Pharmacy Company Information
11.10.2 Yabang Pharmacy Overview
11.10.3 Yabang Pharmacy Erectile Dysfunction Oral Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Yabang Pharmacy Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Yabang Pharmacy Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Erectile Dysfunction Oral Medications Industry Chain Analysis
12.2 Erectile Dysfunction Oral Medications Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Erectile Dysfunction Oral Medications Production Mode & Process
12.4 Erectile Dysfunction Oral Medications Sales and Marketing
12.4.1 Erectile Dysfunction Oral Medications Sales Channels
12.4.2 Erectile Dysfunction Oral Medications Distributors
12.5 Erectile Dysfunction Oral Medications Customers
13 Market Dynamics
13.1 Erectile Dysfunction Oral Medications Industry Trends
13.2 Erectile Dysfunction Oral Medications Market Drivers
13.3 Erectile Dysfunction Oral Medications Market Challenges
13.4 Erectile Dysfunction Oral Medications Market Restraints
14 Key Findings in The Global Erectile Dysfunction Oral Medications Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Erectile Dysfunction Oral Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Sildenafil
Table 3. Major Manufacturers of Tadalafil
Table 4. Major Manufacturers of Others
Table 5. Global Erectile Dysfunction Oral Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Erectile Dysfunction Oral Medications Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Erectile Dysfunction Oral Medications Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Erectile Dysfunction Oral Medications Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Erectile Dysfunction Oral Medications Revenue Market Share by Region (2018-2024)
Table 10. Global Erectile Dysfunction Oral Medications Revenue Market Share by Region (2024-2029)
Table 11. Global Erectile Dysfunction Oral Medications Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Erectile Dysfunction Oral Medications Sales by Region (2018-2024) & (K Units)
Table 13. Global Erectile Dysfunction Oral Medications Sales by Region (2024-2029) & (K Units)
Table 14. Global Erectile Dysfunction Oral Medications Sales Market Share by Region (2018-2024)
Table 15. Global Erectile Dysfunction Oral Medications Sales Market Share by Region (2024-2029)
Table 16. Global Erectile Dysfunction Oral Medications Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Erectile Dysfunction Oral Medications Sales Share by Manufacturers (2018-2024)
Table 18. Global Erectile Dysfunction Oral Medications Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Erectile Dysfunction Oral Medications Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Erectile Dysfunction Oral Medications, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Erectile Dysfunction Oral Medications Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Erectile Dysfunction Oral Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Erectile Dysfunction Oral Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erectile Dysfunction Oral Medications as of 2022)
Table 24. Global Key Manufacturers of Erectile Dysfunction Oral Medications, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Erectile Dysfunction Oral Medications, Product Offered and Application
Table 26. Global Key Manufacturers of Erectile Dysfunction Oral Medications, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Erectile Dysfunction Oral Medications Sales by Type (2018-2024) & (K Units)
Table 29. Global Erectile Dysfunction Oral Medications Sales by Type (2024-2029) & (K Units)
Table 30. Global Erectile Dysfunction Oral Medications Sales Share by Type (2018-2024)
Table 31. Global Erectile Dysfunction Oral Medications Sales Share by Type (2024-2029)
Table 32. Global Erectile Dysfunction Oral Medications Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Erectile Dysfunction Oral Medications Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Erectile Dysfunction Oral Medications Revenue Share by Type (2018-2024)
Table 35. Global Erectile Dysfunction Oral Medications Revenue Share by Type (2024-2029)
Table 36. Erectile Dysfunction Oral Medications Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Erectile Dysfunction Oral Medications Price Forecast by Type (2024-2029) & (US$/Unit)
Table 38. Global Erectile Dysfunction Oral Medications Sales by Application (2018-2024) & (K Units)
Table 39. Global Erectile Dysfunction Oral Medications Sales by Application (2024-2029) & (K Units)
Table 40. Global Erectile Dysfunction Oral Medications Sales Share by Application (2018-2024)
Table 41. Global Erectile Dysfunction Oral Medications Sales Share by Application (2024-2029)
Table 42. Global Erectile Dysfunction Oral Medications Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Erectile Dysfunction Oral Medications Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Erectile Dysfunction Oral Medications Revenue Share by Application (2018-2024)
Table 45. Global Erectile Dysfunction Oral Medications Revenue Share by Application (2024-2029)
Table 46. Erectile Dysfunction Oral Medications Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Erectile Dysfunction Oral Medications Price Forecast by Application (2024-2029) & (US$/Unit)
Table 48. US & Canada Erectile Dysfunction Oral Medications Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Erectile Dysfunction Oral Medications Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Erectile Dysfunction Oral Medications Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Erectile Dysfunction Oral Medications Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Erectile Dysfunction Oral Medications Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Erectile Dysfunction Oral Medications Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Erectile Dysfunction Oral Medications Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Erectile Dysfunction Oral Medications Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Erectile Dysfunction Oral Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Erectile Dysfunction Oral Medications Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Erectile Dysfunction Oral Medications Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Erectile Dysfunction Oral Medications Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Erectile Dysfunction Oral Medications Sales by Country (2024-2029) & (K Units)
Table 61. Europe Erectile Dysfunction Oral Medications Sales by Type (2018-2024) & (K Units)
Table 62. Europe Erectile Dysfunction Oral Medications Sales by Type (2024-2029) & (K Units)
Table 63. Europe Erectile Dysfunction Oral Medications Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Erectile Dysfunction Oral Medications Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Erectile Dysfunction Oral Medications Sales by Application (2018-2024) & (K Units)
Table 66. Europe Erectile Dysfunction Oral Medications Sales by Application (2024-2029) & (K Units)
Table 67. Europe Erectile Dysfunction Oral Medications Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Erectile Dysfunction Oral Medications Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Erectile Dysfunction Oral Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Erectile Dysfunction Oral Medications Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Erectile Dysfunction Oral Medications Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Erectile Dysfunction Oral Medications Sales by Country (2018-2024) & (K Units)
Table 73. Europe Erectile Dysfunction Oral Medications Sales by Country (2024-2029) & (K Units)
Table 74. China Erectile Dysfunction Oral Medications Sales by Type (2018-2024) & (K Units)
Table 75. China Erectile Dysfunction Oral Medications Sales by Type (2024-2029) & (K Units)
Table 76. China Erectile Dysfunction Oral Medications Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Erectile Dysfunction Oral Medications Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Erectile Dysfunction Oral Medications Sales by Application (2018-2024) & (K Units)
Table 79. China Erectile Dysfunction Oral Medications Sales by Application (2024-2029) & (K Units)
Table 80. China Erectile Dysfunction Oral Medications Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Erectile Dysfunction Oral Medications Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Erectile Dysfunction Oral Medications Sales by Type (2018-2024) & (K Units)
Table 83. Asia Erectile Dysfunction Oral Medications Sales by Type (2024-2029) & (K Units)
Table 84. Asia Erectile Dysfunction Oral Medications Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Erectile Dysfunction Oral Medications Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Erectile Dysfunction Oral Medications Sales by Application (2018-2024) & (K Units)
Table 87. Asia Erectile Dysfunction Oral Medications Sales by Application (2024-2029) & (K Units)
Table 88. Asia Erectile Dysfunction Oral Medications Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Erectile Dysfunction Oral Medications Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Erectile Dysfunction Oral Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Erectile Dysfunction Oral Medications Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Erectile Dysfunction Oral Medications Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Erectile Dysfunction Oral Medications Sales by Region (2018-2024) & (K Units)
Table 94. Asia Erectile Dysfunction Oral Medications Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Sales by Country (2024-2029) & (K Units)
Table 108. Eli Lilly Company Information
Table 109. Eli Lilly Description and Major Businesses
Table 110. Eli Lilly Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Eli Lilly Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Eli Lilly Recent Developments
Table 113. Pfizer Company Information
Table 114. Pfizer Description and Major Businesses
Table 115. Pfizer Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Pfizer Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Pfizer Recent Developments
Table 118. Bayer Company Information
Table 119. Bayer Description and Major Businesses
Table 120. Bayer Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Bayer Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Bayer Recent Developments
Table 123. S.K. Chemicals Company Information
Table 124. S.K. Chemicals Description and Major Businesses
Table 125. S.K. Chemicals Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. S.K. Chemicals Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. S.K. Chemicals Recent Developments
Table 128. Teva Pharma Company Information
Table 129. Teva Pharma Description and Major Businesses
Table 130. Teva Pharma Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Teva Pharma Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Teva Pharma Recent Developments
Table 133. Dong-A ST Company Information
Table 134. Dong-A ST Description and Major Businesses
Table 135. Dong-A ST Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Dong-A ST Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Dong-A ST Recent Developments
Table 138. Petros Pharmaceuticals Company Information
Table 139. Petros Pharmaceuticals Description and Major Businesses
Table 140. Petros Pharmaceuticals Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Petros Pharmaceuticals Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Petros Pharmaceuticals Recent Developments
Table 143. Seoul Pharma Company Information
Table 144. Seoul Pharma Description and Major Businesses
Table 145. Seoul Pharma Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Seoul Pharma Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Seoul Pharma Recent Developments
Table 148. BaiYunShan General Factory Company Information
Table 149. BaiYunShan General Factory Description and Major Businesses
Table 150. BaiYunShan General Factory Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. BaiYunShan General Factory Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. BaiYunShan General Factory Recent Developments
Table 153. Yabang Pharmacy Company Information
Table 154. Yabang Pharmacy Description and Major Businesses
Table 155. Yabang Pharmacy Erectile Dysfunction Oral Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Yabang Pharmacy Erectile Dysfunction Oral Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Yabang Pharmacy Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Erectile Dysfunction Oral Medications Distributors List
Table 161. Erectile Dysfunction Oral Medications Customers List
Table 162. Erectile Dysfunction Oral Medications Market Trends
Table 163. Erectile Dysfunction Oral Medications Market Drivers
Table 164. Erectile Dysfunction Oral Medications Market Challenges
Table 165. Erectile Dysfunction Oral Medications Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Erectile Dysfunction Oral Medications Product Picture
Figure 2. Global Erectile Dysfunction Oral Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Erectile Dysfunction Oral Medications Market Share by Type in 2022 & 2029
Figure 4. Sildenafil Product Picture
Figure 5. Tadalafil Product Picture
Figure 6. Others Product Picture
Figure 7. Global Erectile Dysfunction Oral Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Erectile Dysfunction Oral Medications Market Share by Application in 2022 & 2029
Figure 9. Hospital Pharmacies
Figure 10. Private Clinics
Figure 11. Retail Pharmacies
Figure 12. E-Commerce
Figure 13. Erectile Dysfunction Oral Medications Report Years Considered
Figure 14. Global Erectile Dysfunction Oral Medications Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Erectile Dysfunction Oral Medications Revenue 2018-2029 (US$ Million)
Figure 16. Global Erectile Dysfunction Oral Medications Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Erectile Dysfunction Oral Medications Revenue Market Share by Region (2018-2029)
Figure 18. Global Erectile Dysfunction Oral Medications Sales 2018-2029 ((K Units)
Figure 19. Global Erectile Dysfunction Oral Medications Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Erectile Dysfunction Oral Medications Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Erectile Dysfunction Oral Medications Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Erectile Dysfunction Oral Medications Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Erectile Dysfunction Oral Medications Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Erectile Dysfunction Oral Medications Sales YoY (2018-2029) & (K Units)
Figure 25. China Erectile Dysfunction Oral Medications Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Erectile Dysfunction Oral Medications Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Erectile Dysfunction Oral Medications Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Erectile Dysfunction Oral Medications Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Erectile Dysfunction Oral Medications in the World: Market Share by Erectile Dysfunction Oral Medications Revenue in 2022
Figure 32. Global Erectile Dysfunction Oral Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Erectile Dysfunction Oral Medications Sales Market Share by Type (2018-2029)
Figure 34. Global Erectile Dysfunction Oral Medications Revenue Market Share by Type (2018-2029)
Figure 35. Global Erectile Dysfunction Oral Medications Sales Market Share by Application (2018-2029)
Figure 36. Global Erectile Dysfunction Oral Medications Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Erectile Dysfunction Oral Medications Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Erectile Dysfunction Oral Medications Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Erectile Dysfunction Oral Medications Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Erectile Dysfunction Oral Medications Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Erectile Dysfunction Oral Medications Revenue Share by Country (2018-2029)
Figure 42. US & Canada Erectile Dysfunction Oral Medications Sales Share by Country (2018-2029)
Figure 43. U.S. Erectile Dysfunction Oral Medications Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Erectile Dysfunction Oral Medications Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Erectile Dysfunction Oral Medications Sales Market Share by Type (2018-2029)
Figure 46. Europe Erectile Dysfunction Oral Medications Revenue Market Share by Type (2018-2029)
Figure 47. Europe Erectile Dysfunction Oral Medications Sales Market Share by Application (2018-2029)
Figure 48. Europe Erectile Dysfunction Oral Medications Revenue Market Share by Application (2018-2029)
Figure 49. Europe Erectile Dysfunction Oral Medications Revenue Share by Country (2018-2029)
Figure 50. Europe Erectile Dysfunction Oral Medications Sales Share by Country (2018-2029)
Figure 51. Germany Erectile Dysfunction Oral Medications Revenue (2018-2029) & (US$ Million)
Figure 52. France Erectile Dysfunction Oral Medications Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Erectile Dysfunction Oral Medications Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Erectile Dysfunction Oral Medications Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Erectile Dysfunction Oral Medications Revenue (2018-2029) & (US$ Million)
Figure 56. China Erectile Dysfunction Oral Medications Sales Market Share by Type (2018-2029)
Figure 57. China Erectile Dysfunction Oral Medications Revenue Market Share by Type (2018-2029)
Figure 58. China Erectile Dysfunction Oral Medications Sales Market Share by Application (2018-2029)
Figure 59. China Erectile Dysfunction Oral Medications Revenue Market Share by Application (2018-2029)
Figure 60. Asia Erectile Dysfunction Oral Medications Sales Market Share by Type (2018-2029)
Figure 61. Asia Erectile Dysfunction Oral Medications Revenue Market Share by Type (2018-2029)
Figure 62. Asia Erectile Dysfunction Oral Medications Sales Market Share by Application (2018-2029)
Figure 63. Asia Erectile Dysfunction Oral Medications Revenue Market Share by Application (2018-2029)
Figure 64. Asia Erectile Dysfunction Oral Medications Revenue Share by Region (2018-2029)
Figure 65. Asia Erectile Dysfunction Oral Medications Sales Share by Region (2018-2029)
Figure 66. Japan Erectile Dysfunction Oral Medications Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Erectile Dysfunction Oral Medications Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Erectile Dysfunction Oral Medications Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Erectile Dysfunction Oral Medications Revenue (2018-2029) & (US$ Million)
Figure 70. India Erectile Dysfunction Oral Medications Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Erectile Dysfunction Oral Medications Sales Share by Country (2018-2029)
Figure 77. Brazil Erectile Dysfunction Oral Medications Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Erectile Dysfunction Oral Medications Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Erectile Dysfunction Oral Medications Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Erectile Dysfunction Oral Medications Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Erectile Dysfunction Oral Medications Revenue (2018-2029) & (US$ Million)
Figure 82. Erectile Dysfunction Oral Medications Value Chain
Figure 83. Erectile Dysfunction Oral Medications Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed